Monomer-Polymer and Dajac Labs (“MPD”) has undertaken specialty monomer and polymer research for over 50 years, creating an extensive datacenter of highly technical monomers and related polymers and copolymers. MPD specialties include acrylates, methacrylates, fluorinated molecules, silanes and vinyl monomers, in addition to the corresponding polymers and copolymers. MPD’s specialty monomers and polymers are broadly used, serving many markets including coatings, adhesives, medical devices, dental resins, academic and industrial R&D.
The Silar production facilities in Acme, NC and Scotia, NY are primarily engaged in the manufacture of organosilanes, silicones and adhesion promoters for use in pharmaceutical, biomedical devices, electronics, industrial and R&D markets. Silar’s manufacturing facilities are ISO 9002 certified and produces gram and kilo-lab scale through multi-ton at the Acme facility. The staff is lead by a team of veteran scientists and process engineers dedicated to producing the highest quality materials using cost-effective routes and technologies.
“The closing of this transaction strongly positions MPD for the future by combining two complementary chemistries, technical capabilities and strong market channels. Specifically, the ability for Monomer-Polymer and Silar to undertake interdisciplinary R&D and production with specialty monomers and silanes will strengthen the organization’s position in multiple, key markets in which we have seen sustained growth”, said MPD CEO, Stephen Bell.
For more information on this transaction, please contact Stephen Bell, Ph.D.
Company contact information:
Stephen Bell, CEO
Monomer-Polymer and Dajac Labs